Which Transgenic Pig Will Be Used For Islet Transplantation In Humans?
Funder
National Health and Medical Research Council
Funding Amount
$3,031,083.00
Summary
We propose that xenotransplantation of pig islets will cure Type 1 diabetes. This program will generate genetically modified pigs to overcome the molecular differences between pigs and humans by removing a pig gene and inserting several human genes. In addition, we will add immunosuppressive genes and so minimise the need for drug treatment of the diabetic recipient. We will test our hypothesis by transplanting islets from these genetically modified pigs into baboons. We suggest that this will p ....We propose that xenotransplantation of pig islets will cure Type 1 diabetes. This program will generate genetically modified pigs to overcome the molecular differences between pigs and humans by removing a pig gene and inserting several human genes. In addition, we will add immunosuppressive genes and so minimise the need for drug treatment of the diabetic recipient. We will test our hypothesis by transplanting islets from these genetically modified pigs into baboons. We suggest that this will provide an inexhaustible supply of islets for transplantation.Read moreRead less
Integrative Bioinformatic And Experimental Approaches To Define Novel Roles For Genes That Typically Regulate Axon Guidance In Pancreatic Cancer Initiation
Funder
National Health and Medical Research Council
Funding Amount
$587,955.00
Summary
Early detection and intervention would have a dramatic effect on improving the outcomes for pancreatic cancer. This however relies on understanding how the cancer is initiated. New analysis of more than 100 tumours identified aberrations in genes that typically regulate how the nervous system is positioned during development. We want to use novel bioinformatic approaches and a unique experimental method with cells in culture to rapidly and accurately find out which of these genes drives a normal ....Early detection and intervention would have a dramatic effect on improving the outcomes for pancreatic cancer. This however relies on understanding how the cancer is initiated. New analysis of more than 100 tumours identified aberrations in genes that typically regulate how the nervous system is positioned during development. We want to use novel bioinformatic approaches and a unique experimental method with cells in culture to rapidly and accurately find out which of these genes drives a normal pancreatic cell to become a tumour cell.Read moreRead less
Novel Therapeutic Strategies Targeting Aberrant Cell Cycle Regulation In Pancreatic Cancer And Development Of Robust Tissue-based Assay For Biomarkers Of Therapeutic Responsiveness
Funder
National Health and Medical Research Council
Funding Amount
$139,177.00
Summary
The overall aim of my research to assess noel therapeutic strategies in pancreatic cancer. Using new technology, more in depth understanding of pancreatic cancers (PC) is allowing better characterisation of these tumour into distinct molecular phenotypes. Some of these phenotypes are showing response to specific therapies in experimental models. Hence, there is an urgent need to to define these responsive phenotypes to stratify patients to appropriate therapeutic regimens.